Novo Holdings A/S’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-375,000
Closed -$12.8M 39
2024
Q2
$12.8M Buy
+375,000
New +$11.1M 0.69% 31
2022
Q3
Sell
-565,237
Closed -$12.3M 55
2022
Q2
$12.3M Sell
565,237
-1,069,574
-65% -$29.9M 0.6% 30
2022
Q1
$65.6M Sell
1,634,811
-415,635
-20% -$17.4M 3.46% 7
2021
Q4
$97.2M Hold
2,050,446
4.6% 6
2021
Q3
$116M Sell
2,050,446
-595,000
-22% -$36M 6.01% 5
2021
Q2
$152M Hold
2,645,446
6.73% 3
2021
Q1
$167M Hold
2,645,446
6.91% 3
2020
Q4
$88.8M Hold
2,645,446
3.81% 11
2020
Q3
$72.3M Hold
2,645,446
3.59% 10
2020
Q2
$71.6M Hold
2,645,446
4.62% 7
2020
Q1
$38.8M Hold
2,645,446
2.59% 6
2019
Q4
$45.4M Hold
2,645,446
2.92% 6
2019
Q3
$47.9M Hold
2,645,446
8.21% 5
2019
Q2
$52.4M Buy
+2,645,446
New +$50M 7.35% 5

Other funds holding MORF

Novo Holdings A/S's MORF Position: Q3 2024 in Review

Novo Holdings A/S sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 375,000 shares — an estimated $12.8M sold.

Novo Holdings A/S first reported a position in MORF in Q2 2019 and held it in 14 quarters. The position peaked at $167M in Q1 2021. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

  • Novo Holdings A/S reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Novo Holdings A/S sold 375,000 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $12.8M.
  • Novo Holdings A/S first reported a position in Morphic Holding, Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Novo Holdings A/S's Morphic Holding, Inc. Common Stock position peaked at $167M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Novo Holdings A/S's 13F filing for Q3 2024, filed 24 Oct 2024.